Eloxx Pharmaceuticals, Inc.

Home » Eloxx Pharmaceuticals, Inc.

Secondary

Eloxx Pharmaceuticals, Inc.

We are a global biopharmaceutical company focused on discovering and developing novel therapeutics for the treatment of rare and ultra-rare premature stop codon diseases.

Symbol

ELOX

Last Closing Price
$9.75

Shares
5,000,000

Anticipated Date
TBD

Underwriters
Citigroup, Piper Jaffray, Canaccord Genuity, SunTrust Robinson Humphrey

To view the prospectus for Eloxx Pharmaceuticals, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253